0000950170-24-027326.txt : 20240306
0000950170-24-027326.hdr.sgml : 20240306
20240306171534
ACCESSION NUMBER: 0000950170-24-027326
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LENO SAM R
CENTRAL INDEX KEY: 0001238660
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 24727021
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
ownership.xml
4
X0508
4
2024-03-04
0001521036
Lantheus Holdings, Inc.
LNTH
0001238660
LENO SAM R
C/O LANTHEUS HOLDINGS, INC.
201 BURLINGTON ROAD, SOUTH BLDG
BEDFORD
MA
01730
true
false
false
false
false
Common Stock
2024-03-04
4
M
false
2045
16.30
A
59982
D
Common Stock
2024-03-04
4
M
false
7943
12.59
A
67925
D
Common Stock
2024-03-04
4
M
false
8333
6.00
A
76258
D
Common Stock
2024-03-04
4
M
false
4068
64.20
A
80326
D
Common Stock
2024-03-04
4
S
false
5025
64.81
D
75301
D
Common Stock
2024-03-04
4
S
false
17364
65.60
D
57937
D
Stock Option (right to buy)
16.30
2024-03-04
4
M
false
2045
0.00
D
2024-05-16
Common Stock
2045
0
D
Stock Option (right to buy)
12.59
2024-03-04
4
M
false
7943
0.00
D
2025-05-16
Common Stock
7943
0
D
Stock Option (right to buy)
6.00
2024-03-04
4
M
false
8333
0.00
D
2025-06-25
Common Stock
8333
0
D
Stock Option (right to buy)
64.20
2024-03-04
4
M
false
4068
0.00
D
2023-05-06
2032-05-06
Common Stock
4068
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.21 to $65.19, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.21 to $66.14, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The stock options under this grant vested in equal monthly installments over the twelve months beginning on June 16, 2014.
The stock options under this grant vested in equal monthly installments over the twelve months beginning on June 16, 2015.
The stock options under this grant vested in equal annual installments over the three-year period beginning on June 25, 2016.
/s/ Eric M. Green, attorney-in-fact
2024-03-06